Results 141 to 150 of about 694,423 (327)
HEMODIALYSIS AGAINST ACTIVATED CHARCOAL SUSPENSION AS A TREATMENT OF HEPATIC ENCEPHALOPATHY
, 1977 George E. Merino +3 more
openalex +1 more source
Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation
Alimentary Pharmacology &Therapeutics, EarlyView.The novel classification of acute and non‐acute decompensation provides prognostic information, but the role of hospitalisation status should be reconsidered. ABSTRACT Background A more granular understanding of hepatic decompensation in cirrhosis has led to the classification of acute decompensation (AD) and non‐acute decompensation (NAD).
Lucie Simonis +19 more
wiley +1 more source
Clinical and Splenoportographic Studies on 6 Cases with Repeating Hepatic Encephalopathy
, 1978 Masatake Yasumoto +13 more
openalex +2 more sources
Cerebral Ammonia Metabolism in Patients with Severe Liver Disease and Minimal Hepatic Encephalopathy [PDF]
, 1991 Alan H. Lockwood +2 more
openalex +1 more source
Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS
Alimentary Pharmacology &Therapeutics, EarlyView.In patients with cirrhosis undergoing TIPS, frailty—measured by the Liver Frailty Index—improved in those with poor baseline status; therefore, high frailty should not be seen as a contraindication to elective TIPS. Additionally, LFI assessment before TIPS enables identification of patients with excellent survival prognosis.
Martin Andreas Kabelitz +16 more
wiley +1 more source
Lactulose administration on hepatic encephalopathy
, 1974 N Mitsutani +3 more
openalex +2 more sources
Effects of high-normal and low-normal serum potassium levels on hepatic encephalopathy: Facts, half-facts or artifacts? [PDF]
, 1994 Harold O. Conn
openalex +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.We evaluated long‐term outcomes following nucleos(t)ide analogue discontinuation in HBeAg‐negative chronic hepatitis B. HBsAg loss was infrequent. Early HBsAg loss occurred in patients with low end‐of‐treatment HBsAg levels and without ALT flare, whilst late HBsAg loss typically followed ALT flares and was associated with higher end‐of‐treatment HBsAg ...
Simon J. Hume +18 more
wiley +1 more source
Animal versus vegetable protein diet in hepatic encephalopathy [PDF]
, 1993 Harold O. Conn
openalex +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.Features of clinically significant portal hypertension (CSPH) in patients with autoimmune hepatitis indicate a substantial risk for decompensation and impaired transplant‐free survival. Non‐invasive risk prediction based on liver stiffness measurement ≥ 15 kPa and/or thrombocytopenia (< 150 G/L) serves as a valuable surrogate to identify patients at ...
Lukas Burghart +10 more
wiley +1 more source